Protocols are complete & ready to be installed on client scanners, while cloud analytics platform is ready to perform processing & provide deliverables/reports.
Platform comprised of different backend processing techniques. Client facing screens are for cloud based data uploading of imaging data. Library of disease focused risk prediction models under development & will grow with each scan prospective scan that is acquired and processed, along with any retrospective datasets that are analyzed.
CEO, Vanderbilt University-Biomedical Engineering Columbia University-Master’s Applied Physiology New York University-Master’s Applied Clinical Trials
Biography: Imaging Expert – 15+ yrs of domain expertise in global multi-center clinical trials utilizing quantitative imaging. Founder of Image Reading Center, Inc. (an active Imaging Core Lab and Contract Research Organization)
Advanced Degree(s): Vanderbilt University-Biomedical Engineering Columbia University-Master’s Applied Physiology New York University-Master’s Applied Clinical Trials
COO, Columbia University-Master’s in Biotechnology & Entrepreneurship University of California, Berkeley, School of Law-Certificate 500 Startups VC Unlocked: Venture Capital & Early-Stage Investing Drew University-BA in Biological Anthropology
Biography: Entrepreneur, consultant, and advisor driven to architect and invest in disruptive patient-centric & science-driven ventures. 5+ yrs in oncology and genetics drug discovery and development research.Co- founded and licensed out enzyme replacement therapy to small-cap biopharma company. Advises select life science companies, and has successfully assisted in raising capital for early-stage ventures.
Advanced Degree(s): Columbia University-Master’s in Biotechnology & Entrepreneurship University of California, Berkeley, School of Law-Certificate 500 Startups VC Unlocked: Venture Capital & Early-Stage Investing Drew University-BA in Biological Anthropology
CTO, University of Madras-Bachelor’s Degree Computer Engineering University at Buffalo-Master’s Degree Computer Science University of Illinois at Chicago-Doctor of Philosophy (Ph.D.) Bio Engineering, Medical Imaging
Biography: 13+ years Healthcare Solutions Leader, Clinical Research & Diagnostic Applications & Platform. Former Samsung, GE, Toshiba.
Advanced Degree(s): University of Madras-Bachelor’s Degree Computer Engineering University at Buffalo-Master’s Degree Computer Science University of Illinois at Chicago-Doctor of Philosophy (Ph.D.) Bio Engineering, Medical Imaging
Co-Founder, Vanderbilt University-MBA in Finance Connecticut College-BA in Economics
Biography: Active advisor and angel investor. Creating an angel fund among friends. Since 2010, has spent significant time with entrepreneurs connecting them to other entrepreneurs, angel investors, advisors and potential clients of their business. Serves on two non-proitt Boards and several corporate Advisory Boards.
Advanced Degree(s): Vanderbilt University-MBA in Finance Connecticut College-BA in Economics
Personalized digital physical exam to help predict disease risks, by directly assessing the vital organs & tissues from a whole body perspective,utilizing: non-invasive medical imaging to acquire data,automation algorithms to quantify images, and Artificial Intelligence to develop predictive analytics for improved health.
SAAS platform enables access to the latest imaging technology, and support for legacy scanners,while improving accuracy,precision,and standardization across imaging facilities.
Healthcare/medicine is practiced in reaction to a recent injury or presentation of a longer term condition or disease.
Imaging is currently used after a Physical Exam by a physician, as a confirmation of initial findings. Imaging is only applied to a very specific anatomy or area of interest based on a potential diagnosis.
With over 20 years of experience managing global multicenter clinical trials for academic, biotech, pharma companies, we have overseen the evaluation/selection, installation/training, acquisition/quality control, and conduct/outcomes, of quantitative imaging technologies.
Majority of healthcare solutions fall under a reactive model by providing a diagnosis and then treatment. To solve the problem of diagnosing a patient after the onset of a medical condition requires an earlier stage of intervention to better treat, reverse, or inhibit a disease. In order to achieve this, solutions need to exist in a proactive model that identify, measure, and monitor applicable biomarkers that give patients a window of opportunity to prevent disease prior to biological onset.
We are addressing a combined market of $256B
b) these markets include the latest technical advances that are changing the future of healthcare and medicine
c) Combined market of $256B comprised of:
BIOMARKERS $97B (2020)
PRECISION MEDICINE $87B (2023)
MEDICAL IMAGING $46B (2022)
HEALTHCARE ANALYTICS $19B (2020)
MRI SYSTEMS $7B (2020)
By end of Q1 2018 we would have done the following-
Initiated pilot/validation study with key opinion leader/institution
Secured initial client/customer (either biotech/pharma/CRO or health/wellness facility)
Further development of platform
We plan to do the following starting in Q3 2018
Publication of clinical study validation
Submission of regulatory application
Strategic partnerships with pre-release partners
Competitive Advantage- Unique technical expertise in installing & managing advanced imaging technologies to provide a quantitative approach that delivers insights from combined organ & tissue interaction. Unique market insight from experience/expertise evaluating imaging techniques and training hundreds of imaging facilities.
Novelty of technology- Typical imaging companies develop individual techniques that only focus on a single organ or tissue, while we are focused on providing a comprehensive solution beyond what any one single provider could offer.
No new stake holders.
We currently hold an exclusive, worldwide, all domains of practice license for an algorithm to map scar tissue in the heart. We will be developing new IP based off of this core technology, as well as the integration of the different imaging technologies that we are and will be working with.
Current customer is IPMC in South Korea. 3 projects: 100 participants over a period of 1 year, offered for the residents of Paju city, supported by the Korean government.
Project 2: offer annual digital physical examination to employees of 2 large corporate customers
Project 3: Alzheimer’s moonshot project to diagnose, treat and prevent the occurrence of mental disorders
We are on discussions with replicating similar services for precision medicine in China, Middle East, US and Europe.